Ultra-hypofractionated radiation therapy for unfavourable intermediate-risk and high-risk prostate cancer is safe and effective: 5-year outcomes of a phase II trial

  1. Macias, V.A.
  2. Barrera-Mellado, I.
Zeitschrift:
BJU International

ISSN: 1464-410X,  1464-4096

Datum der Publikation: 2020

Ausgabe: 125

Nummer: 2

Seiten: 215-225

Art: Artikel

DOI: 10.1111/BJU.14925 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus